0.7613
1.12%
-0.0086
시간 외 거래:
.8199
0.0586
+7.70%
Gritstone Bio Inc 주식(GRTS)의 최신 뉴스
Beyond The Numbers: 4 Analysts Discuss Gritstone Bio Stock
Benzinga
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Zacks Investment Research
Here's How Cresco Labs (CRLBF) is Placed Before Q1 Earnings
Zacks Investment Research
Should SNDL (SNDL) be in Your Portfolio Ahead of Q1 Earnings?
Zacks Investment Research
Should You Buy Hims & Hers Health (HIMS) Ahead of Q1 Earnings?
Zacks Investment Research
Gritstone bio Inc. (GRTS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks Investment Research
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q1 Earnings
Zacks Investment Research
Down -63.39% in 4 Weeks, Here's Why Gritstone bio (GRTS) Looks Ripe for a Turnaround
Zacks Investment Research
Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering
Seeking Alpha
Gritstone (GRTS) Plummets 58% in a Week: Here's Why
Zacks Investment Research
Nasdaq Down Over 1%; VivoPower International Shares Spike Higher
Benzinga
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Crude Oil Surges Over 1%; US Factory Orders Increase In February
Benzinga
Dow Dips Over 400 Points; Paychex Posts Downbeat Sales
Benzinga
Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Paychex, PVH And 3 Stocks To Watch Heading Into Tuesday
Benzinga
Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
GlobeNewswire Inc.
Gritstone bio Announces Proposed Public Offering
GlobeNewswire Inc.
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
GlobeNewswire Inc.
Do Options Traders Know Something About Gritstone bio (GRTS) Stock We Don't?
Zacks Investment Research
Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
GlobeNewswire Inc.
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Benzinga
C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Misses Revenue Estimates
Zacks Investment Research
Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire Inc.
Gritstone bio Announces Update to Comparative Phase 2b COVID-19 Clinical Trial
GlobeNewswire Inc.
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Gritstone bio to Participate in Upcoming Investor Conference
GlobeNewswire Inc.
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks
MarketWatch
The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks
MarketWatch
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
자본화:
|
볼륨(24시간):